- ►bloodjournal.org [PDF] MM Horowitz, RP Gale, PM Sondel, JM Goldman, J … - Blood, 1990 - Am Soc Hematology ONSIDERABLE EXPERIMENTAL data suggest a C possible role for the immune system in controlling ... In this study we examined the results of bone marrow transplantation in 2,254 patients with
early leukemia for evidence of graft-related antileukemia effects both in associ- ation with ... Cited by 1417 - Related articles - All 4 versions
- ►nih.gov [PDF] SA Rosenberg, MT Lotze, JC Yang, PM … - Annals of …, 1989 - pubmedcentral.nih.gov We have administered 1039 courses of high-dose interleukin-2 (IL-2) to 652 cancer patients.
Five hundred ninety-six patients had metastatic cancer that either had failed standard effective
therapies or haddisease for which no standard effective therapy existed, and 56 patients ... Cited by 681 - Related articles - All 4 versions
- ►nih.gov [PDF] VS Byers, RW Baldwin - Immunology, 1988 - pubmedcentral.nih.gov Introduction Monoclonal antibodies (mAbs) are emerging as a major modality for both detection
and therapy of various pathological conditions, including malignant disease. Murine monoclonal
antibodies have been developed which react with tumour- associated antigens ... Cited by 59 - Related articles - All 3 versions
- ►clinchem.org [PDF] LM Shaw - Clinical Chemistry, 1989 - Am Assoc Clin Chem This review will focus on our current state of understanding of the cellular and molecular mechanisms
by which CsA exerts immunosuppression and will present new information on: pharmacokinetic
variability of CsA, selection of specimen and method for measuring CsA concentration, ... Cited by 56 - Related articles - All 2 versions
- ►jcojournal.org [PDF] GV Dahl, DK Kalwinsky, J Mirro Jr, AT Look, CH … - Journal of Clinical …, 1990 - jcojournal.org DESPITE PROGRESS in devising effective remission induction therapy and improv- ing methods
of supportive care for children and adults with acute nonlymphocytic leukemia (ANLL), most patients
still succumb after bone marrow recurrences that develop during postre- mission ... Cited by 50 - Related articles - All 6 versions
F Goldstein - Journal of clinical gastroenterology, 1987 - journals.lww.com J Clin Gastroenterol 9(6): 654-658, 1987. 1987 Raven Press, Ltd., New York Immunosuppressant
Therapy of Inflammatory Bowel Disease Pharmacologic and Clinical Aspects Franz
Goldstein, md The history of immunosuppressant drug use, both azathio- prine (Aza) and ... Cited by 48 - Related articles - All 3 versions
ED Rosenstein, S Ribot, E Ventresca, N Kramer - Rheumatology, 1994 - Br Soc Rheumatology WEGENER'S granulomatosis (WG) is a granulomatous vasculitic disorder with predilection for
involvement of the upper and lower respiratory tracts and the kidneys. The introduction of glucocorticoids
and cytotoxic ther- apy has offered dramatic therapeutic efficacy [1, 2]. Despite initial ... Cited by 21 - Related articles - All 3 versions
JD SMILEY, SE MOORE - The American Journal of the Medical …, 1988 - journals.lww.com Southwestern Internal Medicine Conference: Molecular Mechanisms of Autoimmunity BY J. DONALD
SMILEY, MD, STERLING E. MOORE, Jr, MD ABSTRACT: Autoimmune diseases result from a
combination of genetic susceptibility factors and exogenous influences such as infection ... Cited by 8 - Related articles - All 2 versions
R CSEUZ, GS Panayi - Rheumatology, 1990 - Br Soc Rheumatology Treatment with azathioprine of patients with rheumatoid arthritis leads to a dramatic reduction
in the 4 h NK cytotoxicity against K562 cells. The 24 hcytotoxicity against K562and U937
cells, however, remains intact. The generation of cell-free supernatant cytotoxic factor(s) ... Cited by 8 - Related articles - All 3 versions
